65,437 trials
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
Primary: Objective Response Rate (ORR) — 48.3 percentage of participants
Pain · Fever
Primary: Number of Participants Reporting Safe Dosing at 48-72 Hours — 28; 25 Participants
Postpartum Anemia Nos
Primary: Total Number of Units Transfused — 1.2; 2.1 units of blood — p=<0.001
Lip Rejuvenation
Primary: First Impressions — 46.756; 27.769; 46.391; 34.404 score on a scale
Adult Diffuse Astrocytoma · Adult Mixed Glioma · Adult Oligodendroglioma
Primary: Progression-free Survival (PFS) of Low Grade Glioma Patients Treated With Autologous Dendritic Cells Pulsed With Autologous Tumor Lysate — 0; 1; 1; 1 participants
Trichotillomania · Hair Pulling Disorder
Primary: Change in NIMH Trichotillomania Severity Scale (NIMH-TSS) Scores — 9.4; 9.4; 6.3; 7.4 score on a scale
Pneumococcal Disease
Primary: Percentage of Participants With Local Reactions Within 10 Days After Vaccination — 7.0; 6.2; 3.9; 3.3 percentage of participants
Hernia · Postoperative Pain
Primary: Total Use of Opioid Analgesia - Morphine Equivalence (mg) — 19.3 Morphine Equivalence (mg)
Healthy
Primary: AUC0 - t — 19704.2; 20736.9 h*ug/mL — p=>0.05
Concussion, Mild · Concussion, Brain
Primary: Pre-season to Post-season DTI Percentage Change — -0.17; -1.27; 0.45; 2.83 percentage of change
Malocclusion
Primary: Successful Correction of Malocclusion — 32; 20 Participants
Fluid Retention Tissue
Primary: Difference in Correlation of Thoracic Impedance With Ultra-filtration Volume (UFV) Between uCor and ZOE — 0.66; 0.23 difference in correlation coefficients
Rhinoplasty
Primary: Live Assessment of Satisfaction With the Grafts — 2; 4 units on a scale
Healthy
Primary: Percentage of Participants With Solicited Local Adverse Events (AEs) Post Vaccination — 88.0; 83.7; 75.5; 77.1 percentage of participants
Pain, Postoperative
Primary: Total Amount of Opioid Rescue Analgesia Used — 46.85; 67.03 Morphine Milligrams